75
Views
0
CrossRef citations to date
0
Altmetric
Review Article

The DST gene in neurobiology

ORCID Icon & ORCID Icon
Pages 131-138 | Received 07 Sep 2023, Accepted 13 Feb 2024, Published online: 11 Mar 2024

References

  • Ali, A., Hu, L., Zhao, F., Qiu, W., Wang, P., Ma, X., Zhang, Y., Chen, L., & Qian, A. (2017). BPAG1, a distinctive role in skin and neurological diseases. Seminars in Cell & Developmental Biology, 69, 34–39. doi:10.1016/j.semcdb.2017.06.005.
  • Ase, A. R., Strazielle, C., Hébert, C., Botez, M. I., LaLonde, R., Descarries, L., & Reader, T. A. (2000). The central serotonin system in dystonia musculorum mutant mice: biochemical, autoradiographic and immunocytochemical data. Synapse, 37(3), 179–193. doi:10.1002/1098-2396(20000901)37:3<179::AID-SYN2>3.0.CO;2-0.
  • Bernier, G., & Kothary, R. (1998). Prenatal onset of axonopathy in dystonia musculorum mice. Developmental Genetics, 22(2), 160–168. doi:10.1002/(SICI)1520-6408(1998)22:2<160::AID-DVG5>3.0.CO;2-4.
  • Bernier, G., Brown, A., Dalpé, G., De Repentigny, Y., Mathieu, M., & Kothary, R. (1995). Dystonin expression in the developing nervous system predominates in the neurons that degenerate in dystonia musculorum mutant mice. Molecular and Cellular Neurosciences, 6(6), 509–520. doi:10.1006/mcne.1995.0003.
  • Bernier, G., De Repentigny, Y., Mathieu, M., David, S., & Kothary, R. (1998). Dystonin is an essential component of the Schwann cell cytoskeleton at the time of myelination. Development (Cambridge, England), 125(11), 2135–2148. doi:10.1242/dev.125.11.2135.
  • Bhanot, K., Young, K. G., & Kothary, R. (2011). MAP1B and clathrin are novel interacting partners of the giant cyto-linker dystonin. Journal of Proteome Research, 10(11), 5118–5127. doi:10.1021/pr200564g.
  • Bronson, R. T., Sweet, H. O., Spencer, C. A., & Davisson, M. T. (1992). Genetic and age related models of neurodegeneration in mice: dystrophic axons. Journal of Neurogenetics, 8(2), 71–83. doi:10.3109/01677069209084153.
  • Brown, A., Bernier, G., Mathieu, M., Rossant, J., & Kothary, R. (1995). The mouse dystonia musculorum gene is a neural isoform of bullous pemphigoid antigen 1. Nature Genetics, 10(3), 301–306. doi:10.1038/ng0795-301.
  • Carlsten, J. A., Kothary, R., & Wright, D. E. (2001). Glial cell line-derived neurotrophic factor-responsive and neurotrophin-3-responsive neurons require the cytoskeletal linker protein dystonin for postnatal survival. The Journal of Comparative Neurology, 432(2), 155–168. doi:10.1002/cne.1094.
  • Campbell, R. M., & Peterson, A. C. (1992). An intrinsic neuronal defect operates in dystonia musculorum: a study of dt/dt⇔+/+ chimeras. Neuron, 9(4), 693–703. doi:10.1016/0896-6273(92)90032-9.
  • Cappuccio, G., Pinelli, M., Torella, A., Alagia, M., Auricchio, R., Staiano, A., Nigro, V., T.U.D.P., & Brunetti-Pierri, N. (2017). Expanding the phenotype of DST-related disorder: a case report suggesting a genotype/phenotype correlation. American Journal of Medical Genetics. Part A, 173(10), 2743–2746. doi:10.1002/ajmg.a.38367.
  • Capri, Y., Bourmance, L., Dupont, C., Saint-Frison, M. H., Guimiot, F., Grotto, S., Chitrit, Y., Laquerrière, A., & Melki, J. (2023). DST variants are responsible for neurogenic arthrogryposis multiplex congenita enlarging the spectrum of type VI hereditary sensory autonomic neuropathy. Clinical Genetics, 104(5), 587–592. doi:10.1111/cge.14397.
  • Chen, Y., Hong, Z., Wang, J., Liu, K., Liu, J., Lin, J., Feng, S., Zhang, T., Shan, L., Liu, T., Guo, P., Lin, Y., Li, T., Chen, Q., Jiang, X., Li, A., Li, X., Li, Y., Wilde, J. J., Bao, J., Dai, J., & Lu, Z. (2023). Circuit-specific gene therapy reverses core symptoms in a primate Parkinson’s disease model. Cell, 186S0092-8674(24), 5394–5410.e18. doi:10.1016/j.cell.2023.10.004.
  • Choong, C. J., Baba, K., & Mochizuki, H. (2016). Gene therapy for neurological disorders. Expert Opinion on Biological Therapy, 16(2), 143–159. doi:10.1517/14712598.2016.1114096.
  • Clément, C., Lalonde, R., & Strazielle, C. (2012). Acetylcholinesterase activity in the brain of dystonia musculorum Dstdt-J mutant mice. Neuroscience Research, 72(1), 79–86. doi:10.1016/j.neures.2011.09.005.
  • Combs, B., Kneynsberg, A., & Kanaan, N. M. (2016). Gene therapy models of Alzheimer’s disease and other dementias. Methods in Molecular Biology (Clifton, N.J.), 1382, 339–366. doi:10.1007/978-1-4939-3271-9_25.
  • Dalpé, G., Leclerc, N., Vallée, A., Messer, A., Mathieu, M., De Repentigny, Y., & Kothary, R. (1998). Dystonin is essential for maintaining neuronal cytoskeleton organization. Molecular and Cellular Neurosciences, 10(5/6), 243–257. doi:10.1006/mcne.1997.0660.
  • Dalpé, G., Mathieu, M., Comtois, A., Zhu, E., Wasiak, S., De Repentigny, Y., Leclerc, N., & Kothary, R. (1999). Dystonin-deficient mice exhibit an intrinsic muscle weakness and an instability of skeletal muscle cytoarchitecture. Developmental Biology, 210(2), 367–380. doi:10.1006/dbio.1999.9263.
  • De Repentigny, Y., Deschênes-Furry, J., Jasmin, B. J., & Kothary, R. (2003). Impaired fast axonal transport in neurons of the sciatic nerves from dystonia musculorum mice. Journal of Neurochemistry, 86(3), 564–571. doi:10.1046/j.1471-4159.2003.01861.x.
  • De Repentigny, Y., Ferrier, A., Ryan, S. D., Sato, T., & Kothary, R. (2011). Motor unit abnormalities in dystonia musculorum mice. PLoS One, 6(6), e21093. doi:10.1371/journal.pone.0021093.
  • Dowling, J., Yang, Y., Wollmann, R., Reichardt, L. F., & Fuchs, E. (1997). Developmental expression of BPAG1-n: insights into the spastic ataxia and gross neurologic degeneration in dystonia musculorum mice. Developmental Biology, 187(2), 131–142. doi:10.1006/dbio.1997.8567.
  • Duchen, L. W. (1976). Dystonia musculorum, an inherited disease of the nervous system of the mouse. Advances in Neurology, 14, 353–365.
  • Duchen, L. W., Strich, S. J., & Falconer, D. S. (1964). Clinical and pathological studies of an hereditary neuropathy in mice (Dystonia musculorum). Brain : A Journal of Neurology, 87(2), 367–378. doi:10.1093/brain/87.2.367.
  • Edvardson, S., Cinnamon, Y., Jalas, C., Shaag, A., Maayan, C., Axelrod, F. B., & Elpeleg, O. (2012). Hereditary sensory autonomic neuropathy caused by a mutation in dystonin. Annals of Neurology, 71(4), 569–572. doi:10.1002/ana.23524.
  • Ferrier, A., Boyer, J. G., & Kothary, R. (2013). Cellular and molecular biology of neuronal dystonin. International Review of Cell and Molecular Biology, 300, 85–120. doi:10.1016/B978-0-12-405210-9.00003-5.
  • Ferrier, A., De Repentigny, Y., Lynch-Godrei, A., Gibeault, S., Eid, W., Kuo, D., Zha, X., & Kothary, R. (2015). Disruption in the autophagic process underlies the sensory neuropathy in dystonia musculorum mice. Autophagy, 11(7), 1025–1036. doi:10.1080/15548627.2015.1052207.
  • Ferrier, A., Sato, T., De Repentigny, Y., Gibeault, S., Bhanot, K., O'Meara, R. W., Lynch-Godrei, A., Kornfeld, S. F., Young, K. G., & Kothary, R. (2014). Transgenic expression of neuronal dystonin isoform 2 partially rescues the disease phenotype of the dystonia musculorum mouse model of hereditary sensory autonomic neuropathy VI. Human Molecular Genetics, 23(10), 2694–2710. doi:10.1093/hmg/ddt663.
  • Fortugno, P., Angelucci, F., Cestra, G., Camerota, L., Ferraro, A. S., Cordisco, S., Uccioli, L., Castiglia, D., De Angelis, B., Kurth, I., Kornak, U., & Brancati, F. (2019). Recessive mutations in the neuronal isoforms of DST, encoding dystonin, lead to abnormal actin cytoskeleton organization and HSAN type VI. Human Mutation, 40(1), 106–114. doi:10.1002/humu.23678.
  • Giorda, R., Cerritello, A., Bonaglia, M. C., Bova, S., Lanzi, G., Repetti, E., Giglio, S., Baschirotto, C., Pramparo, T., Avolio, L., Bragheri, R., Maraschio, P., & Zuffardi, O. (2004). Selective disruption of muscle and brain-specific BPAG1 isoforms in a girl with a 6;15 translocation, cognitive and motor delay, and tracheo-oesophageal atresia. Journal of Medical Genetics, 41(6), e71–e71. doi:10.1136/jmg.2003.012260.
  • Goryunov, D., Adebola, A., Jefferson, J. J., Leung, C. L., Messer, A., & Liem, R. K. (2007). Molecular characterization of the genetic lesion in dystonia musculorum (dt-Alb) mice. Brain Research, 1140, 179–187. doi:10.1016/j.brainres.2006.04.068.
  • Guo, L., Degenstein, L., Dowling, J., Yu, Q. C., Wollmann, R., Perman, B., & Fuchs, E. (1995). Gene targeting of BPAG1: abnormalities in mechanical strength and cell migration in stratified epithelia and neurologic degeneration. Cell, 81(2), 233–243. doi:10.1016/0092-8674(95)90333-x.
  • Hartmann, N., Martrette, J. M., Strazielle, C., & Westphal, A. (1999). Dystonia musculorum mutation and myosin heavy chain expression in skeletal and cardiac muscles. Journal of Cellular Biochemistry, 74(1), 90–98. doi:10.1002/(SICI)1097-4644(19990701)74:1<90::AID-JCB10>3.3.CO;2-H.
  • Hirch, T., Brander, N., Schenk, F., Pöllmann, S. J., Reichenbach, J., Schubert, R., & Modlich, U. (2023). Expression of a large coding sequence: Gene therapy vectors for Ataxia Telangiectasia. Scientific Reports, 13(1), 19386. doi:10.1038/s41598-023-46332-4.
  • Horie, M., Watanabe, K., Bepari, A. K., Nashimoto, J., Araki, K., Sano, H., Chiken, S., Nambu, A., Ono, K., Ikenaka, K., Kakita, A., Yamamura, K., & Takebayashi, H. (2014). Disruption of actin-binding domain-containing Dystonin protein causes dystonia musculorum in mice. The European Journal of Neuroscience, 40(10), 3458–3471. doi:10.1111/ejn.12711.
  • Horie, M., Yoshioka, N., Kusumi, S., Sano, H., Kurose, M., Watanabe-Iida, I., Hossain, I., Chiken, S., Abe, M., Yamamura, K., Sakimura, K., Nambu, A., Shibata, M., & Takebayashi, H. (2020). Disruption of dystonin in Schwann cells results in late-onset neuropathy and sensory ataxia. Glia, 68(11), 2330–2344. doi:10.1002/glia.23843.
  • Horie, M., Mekada, K., Sano, H., Kikkawa, Y., Chiken, S., Someya, T., Saito, K., Hossain, M. I., Nameta, M., Abe, K., Sakimura, K., Ono, K., Nambu, A., Yoshiki, A., & Takebayashi, H. (2016). Characterization of novel dystonia musculorum mutant mice: implications for central nervous system abnormality. Neurobiology of Disease, 96, 271–283. doi:10.1016/j.nbd.2016.09.016.
  • Hossain, M. I., Horie, M., & Takebayashi, H. (2018a). Reduced proliferation of oligodendrocyte progenitor cells in the postnatal brain of dystonia musculorum mice. Neurochemical Research, 43(1), 101–109. doi:10.1007/s11064-017-2342-5.
  • Hossain, M. I., Horie, M., Yoshioka, N., Kurose, M., Yamamura, K., & Takebayashi, H. (2018b). Motoneuron degeneration in the trigeminal motor nucleus innervating the masseter muscle in dystonia musculorum mice. Neurochemistry International, 119, 159–170. doi:10.1016/j.neuint.2017.10.009.
  • Ichikawa, H., De Repentigny, Y., Kothary, R., & Sugimoto, T. (2006). The survival of vagal and glossopharyngeal sensory neurons is dependent upon dystonin. Neuroscience, 137(2), 531–536. doi:10.1016/j.neuroscience.2005.08.081.
  • Ichikawa, H., Terayama, R., Yamaai, T., De Repentigny, Y., Kothary, R., & Sugimoto, T. (2008). The number of nociceptors in the trigeminal ganglion but not proprioceptors in the mesencephalic trigeminal tract nucleus is reduced in dystonin deficient dystonia musculorum mice. Brain Research, 1226, 33–38. doi:10.1016/j.brainres.2008.05.063.
  • Janota, I. (1972). Ultrastructural studies of an hereditary sensory neuropathy in mice (dystonia musculorum). Brain : a Journal of Neurology, 95(3), 529–536. doi:10.1093/brain/95.3.529.
  • Jefferson, J. J., Leung, C. L., & Liem, R. K. (2006). Dissecting the sequence specific functions of alternative N-terminal isoforms of mouse bullous pemphigoid antigen 1. Experimental Cell Research, 312(15), 2712–2725. doi:10.1016/j.yexcr.2006.04.025.
  • Jin, J. Y., Wu, P. F., He, J. Q., Fan, L. L., Yuan, Z. Z., Pang, X. Y., Tang, J. Y., & Zhang, L. Y. (2020). Novel compound heterozygous DST variants causing hereditary sensory and autonomic neuropathies VI in twins of a Chinese family. Frontiers in Genetics, 11, 492. doi:10.3389/fgene.2020.00492.
  • Khalesi, R., Harvey, N., Garshasbi, M., Kalamati, E., Youssefian, L., Vahidnezhad, H., & Uitto, J. (2022). Pathogenic DST sequence variants result in either epidermolysis bullosa simplex (EBS) or hereditary sensory and autonomic neuropathy type 6 (HSAN-VI). Experimental Dermatology, 31(6), 949–955. doi:10.1111/exd.14562.
  • Kornfeld, S. F., Lynch-Godrei, A., Bonin, S. R., Gibeault, S., De Repentigny, Y., & Kothary, R. (2016). Cytoskeletal linker protein dystonin this not critical to terminal oligodendrocyte differentiation or CNS myelination. PLoS One, 11(2), e0149201. doi:10.1371/journal.pone.0149201.
  • Kothary, R., Clapoff, S., Brown, A., Campbell, R., Peterson, A., & Rossant, J. (1988). A transgene containing lacZ inserted into the dystonia locus is expressed in neural tube. Nature, 335(6189), 435–437. doi:10.1038/335435a0.
  • Künzli, K., Favre, B., Chofflon, M., & Borradori, L. (2016). One gene but different proteins and diseases: the complexity of dystonin and bullous pemphigoid antigen 1. Experimental Dermatology, 25(1), 10–16. doi:10.1111/exd.12877.
  • Lalonde, R., & Strazielle, C. (1999). Motor performance of spontaneous murine mutations with cerebellar atrophy. In W. Crusio, R. Gerlai, (Eds.), Handbook of molecular–genetic techniques for brain and behavior research. Techniques in Behavioral and Neural Sciences., vol. 13, pp. 627–637. Elsevier, Amsterdam.
  • Lalonde, R., Joyal, C. C., & Botez, M. I. (1994). Exploration and motor coordination in dystonia musculorum mutant mice. Physiology & Behavior, 56(2), 277–280. doi:10.1016/0031-9384(94)90195-3.
  • Lalonde, R., Marchetti, N., & Strazielle, C. (2005). Primary neurologic screening and motor coordination of Dstdt-J mutant mice (dystonia musculorum) with spinocerebellar atrophy. Physiology & Behavior, 86(1-2), 46–51. doi:10.1016/j.physbeh.2005.06.028.
  • Lalonde, R., Joyal, C. C., & Cote, C. (1993). Swimming activity in dystonia musculorum mutant mice. Physiology & Behavior, 54(1), 119–120. doi:10.1016/0031-9384(93)90052-h.
  • Leung, C. L., Sun, D., & Liem, R. K. (1999). The intermediate filament protein peripherin is the specific interaction partner of mouse BPAG1-n (dystonin) in neurons. The Journal of Cell Biology, 144(3), 435–446. doi:10.1083/jcb.144.3.435.
  • Leung, C. L., Zheng, M., Prater, S. M., & Liem, R. K. (2001). The BPAG1 locus: Alternative splicing produces multiple isoforms with distinct cytoskeletal linker domains, including predominant isoforms in neurons and muscles. The Journal of Cell Biology, 154(4), 691–697. doi:10.1083/jcb.200012098.
  • Litjens, S. H., Koster, J., Kuikman, I., van Wilpe, S., de Pereda, J. M., & Sonnenberg, A. (2003). Specificity of binding of the plectin actin-binding domain to β4 integrin. Molecular Biology of the Cell, 14(10), 4039–4050. doi:10.1091/mbc.e03-05-0268.
  • Liu, J. J., Ding, J., Wu, C., Bhagavatula, P., Cui, B., Chu, S., Mobley, W. C., & Yang, Y. (2007). Retrolinkin, a membrane protein, plays an important role in retrograde axonal transport. Proceedings of the National Academy of Sciences of the United States of America, 104(7), 2223–2228. doi:10.1073/pnas.0602222104.
  • Liu, J. J., Ding, J., Kowal, A. S., Nardine, T., Allen, E., Delcroix, J. D., Wu, C., Mobley, W., Fuchs, E., & Yang, Y. (2003). BPAG1n4 is essential for retrograde axonal transport in sensory neurons. The Journal of Cell Biology, 163(2), 223–229. doi:10.1083/jcb.200306075.
  • Lynch-Godrei, A., & Kothary, R. (2016). Functional and genetic analysis of neuronal isoforms of BPAG1. Methods in Enzymology, 569, 355–372. doi:10.1016/bs.mie.2015.05.004.
  • Lynch-Godrei, A., & Kothary, R. (2020). HSAN-VI: a spectrum disorder based on dystonin isoform expression. Neurology Genetics, 6(1), e389. doi:10.1212/NXG.0000000000000389.
  • Lynch-Godrei, A., De Repentigny, Y., Ferrier, A., Gagnon, S., & Kothary, R. (2021). Dystonin loss-of-function leads to impaired autophagosome-endolysosome pathway dynamics. Biochemistry and Cell Biology = Biochimie et Biologie Cellulaire, 99(3), 364–373. doi:10.1139/bcb-2020-0557.
  • Lynch-Godrei, A., De Repentigny, Y., Gagnon, S., Trung, M. T., & Kothary, R. (2018). Dystonin-A3 upregulation is responsible for maintenance of tubulin acetylation in a less severe dystonia musculorum mouse model for hereditary sensory and autonomic neuropathy type VI. Human Molecular Genetics, 27(20), 3598–3611. doi:10.1093/hmg/ddy250.
  • Manganelli, F., Parisi, S., Nolano, M., Tao, F., Paladino, S., Pisciotta, C., Tozza, S., Nesti, C., Rebelo, A. P., Provitera, V., Santorelli, F. M., Shy, M. E., Russo, T., Zuchner, S., & Santoro, L. (2017). Novel mutations in dystonin provide clues to the pathomechanisms of HSAN-VI. Neurology, 88(22), 2132–2140. doi:10.1212/WNL.0000000000003992.
  • Messer, A. (1982). Amino acid changes in the mouse mutant dystonia musculorum similar to those in Friedreich’s ataxia. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques, 9(2), 185–188. doi:10.1017/s0317167100043936.
  • Messer, A., & Gordon, D. (1979). Changes in whole tissue biosynthesis of gamma-amino butyric acid (GABA) in basal ganglia of the dystonia (dtAlb) mouse. Life Sciences, 25(26), 2217–2221. doi:10.1016/0024-3205(79)90095-x.
  • Messer, A., & Strominger, N. L. (1980). An allele of the mouse mutant dystonia musculorum exhibits lesions in red nucleus and striatum. Neuroscience, 5(3), 543–549. doi:10.1016/0306-4522(80)90051-2.
  • Motley, W. W., Züchner, S., & Scherer, S. S. (2020). Isoform-specific loss of dystonin causes hereditary motor and sensory neuropathy. Neurology Genetics, 6(5), e496. doi:10.1212/NXG.0000000000000496.
  • Moss, T. H. (1981). Segmental demyelination in the peripheral nerves of mice affected by a hereditary neuropathy (dystonia musculorum). Acta Neuropathologica, 53(1), 51–56. doi:10.1007/BF00697184.
  • Muñoz-Lasso, D. C., Romá-Mateo, C., Pallardó, F. V., & Gonzalez-Cabo, P. (2020). Much more than a scaffold: cytoskeletal proteins in neurological disorders. Cells, 9(2), 358. doi:10.3390/cells9020358.
  • Muppirala, A. N., Limbach, L. E., Bradford, E. F., & Petersen, S. C. (2020). Schwann cell development: From neural crest to myelin sheath. Wiley Interdisciplinary Reviews. Developmental Biology, 10(5), e398. doi:10.1002/wdev.398.
  • Nodari, A., Previtali, S. C., Dati, G., Occhi, S., Court, F. A., Colombelli, C., Zambroni, D., Dina, G., Del Carro, U., Campbell, K. P., Quattrini, A., Wrabetz, L., & Feltri, M. L. (2008). Alpha6beta4 integrin and dystroglycan cooperate to stabilize the myelin sheath. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 28(26), 6714–6719. doi:10.1523/JNEUROSCI.0326-08.2008.
  • Ongali, B., Ase, A. R., Hébert, C., Amdiss, F., & Reader, T. A. (2000). Dopamine D(1) and D(2) receptors in the forebrain of dystonia musculoruminItalics mutant mice: an autoradiographic survey in relation to dopamine contents. Synapse, 37(1), 1–15. doi:10.1002/(SICI)1098-2396(200007)37:1<1::AID-SYN1>3.0.CO;2-9.
  • Pena, S. A., Iyengar, R., Eshraghi, R. S., Bencie, N., Mittal, J., Aljohani, A., Mittal, R., & Eshraghi, A. A. (2020). Gene therapy for neurological disorders: challenges and recent advancements. Journal of Drug Targeting, 28(2), 111–128. doi:10.1080/1061186X.2019.1630415.
  • Perkins, A. S. (2002). Functional genomics in the mouse. Functional & Integrative Genomics, 2(3), 81–91. doi:10.1007/s10142-002-0049-3.
  • Poliakova, K., Adebola, A., Leung, C. L., Favre, B., Liem, R. K., Schepens, I., & Borradori, L. (2014). BPAG1a and b associate with EB1 and EB3 and modulate vesicular transport, Golgi apparatus structure, and cell migration in C2.7 myoblasts. PLoS One, 9(9), e107535. doi:10.1371/journal.pone.0107535.
  • Ponomarev, A. S., Chulpanova, D. S., Yanygina, L. M., Solovyeva, V. V., & Rizvanov, A. A. (2023). Emerging gene therapy approaches in the management of spinal muscular atrophy (SMA): An overview of clinical trials and patent landscape. International Journal of Molecular Sciences, 24(18), 13743. doi:10.3390/ijms241813743.
  • Pool, M., Rippstein, P., McBride, H., & Kothary, R. (2006). Trafficking of macromolecules and organelles in cultured dystonia musculorumin sensory neurons is normal. The Journal of Comparative Neurology, 494(4), 549–558. doi:10.1002/cne.20815.
  • Pool, M., Boudreau Larivière, C., Bernier, G., Young, K. G., & Kothary, R. (2005). Genetic alterations at the Bpag1 locus in dt mice and their impact on transcript expression. Mammalian Genome: Official Journal of the International Mammalian Genome Society, 16(12), 909–917. doi:10.1007/s00335-005-0073-4.
  • Riker, D. K., Messer, A., & Roth, R. H. (1981). Increased noradrenergic metabolism in the cerebellum of the mouse mutant dystonia musculorum. Journal of Neurochemistry, 37(3), 649–654. doi:10.1111/j.1471-4159.1982.tb12536.x.
  • Rojsajjakul, T., Hordeaux, J. J., Choudhury, G. R., Hinderer, C. J., Mesaros, C., Wilson, J. M., & Blair, I. A. (2023). Quantification of human mature frataxin protein expression in nonhuman primate hearts after gene therapy. Communications Biology, 6(1), 1093. doi:10.1038/s42003-023-05472-z.
  • Ryan, S. D., Bhanot, K., Ferrier, A., De Repentigny, Y., Chu, A., Blais, A., & Kothary, R. (2012a). Microtubule stability, Golgi organization, and transport flux require dystonin-a2-MAP1B interaction. The Journal of Cell Biology, 196(6), 727–742. doi:10.1083/jcb.201107096.
  • Ryan, S. D., Ferrier, A., Sato, T., O'Meara, R. W., De Repentigny, Y., Jiang, S. X., Hou, S. T., & Kothary, R. (2012b). Neuronal dystonin isoform 2 is a mediator of endoplasmic reticulum structure and function. Molecular Biology of the Cell, 23(4), 553–566. doi:10.1091/mbc.E11-06-0573.
  • Sakaria, R. P., Fonville, M. P., Peravali, S., Zaveri, P. G., Mroczkowski, H. J., Caron, E., & Weems, M. F. (2022). A novel variant in the dystonin gene causing hereditary sensory autonomic neuropathy type VI in a male infant: Case report and literature review. American Journal of Medical Genetics. Part A, 188(4), 1245–1250. doi:10.1002/ajmg.a.62609.
  • Saulnier, R., De Repentigny, Y., Yong, V. W., & Kothary, R. (2002). Alterations in myelination in the central nervous system of dystonia musculorum mice. Journal of Neuroscience Research, 69(2), 233–242. doi:10.1002/jnr.10289.
  • Seehusen, F., Kiel, K., Jottini, S., Wohlsein, P., Habierski, A., Seibel, K., Vogel, T., Urlaub, H., Kollmar, M., Baumgärtner, W., & Teichmann, U. (2016). Axonopathy in the central nervous system is the hallmark of mice with a novel intragenic null mutation of dystonin. Genetics, 204(1), 191–203. doi:10.1534/genetics.116.186932.
  • Sotelo, C., & Guenet, J. L. (1988). Pathologic changes in the CNS of dystonia musculorum mutant mouse: an animal model for human spinocerebellar ataxia. Neuroscience, 27(2), 403–424. doi:10.1016/0306-4522(88)90277-1.
  • Stanley, E., Messer, A., & Strominger, N. L. (1983). Effects of age and strain differences on the red nucleus of the mouse mutant dystonia musculorum. The Anatomical Record, 206(3), 313–318. doi:10.1002/ar.1092060310.
  • Strazielle, C., Ase, A. R., Lalonde, R., & Reader, T. (2002). Biochemical and autoradiographic studies of the central noradrenergic system in dystonia musculorum mutant mice. Journal of Chemical Neuroanatomy, 23(2), 143–155. doi:10.1016/s0891-0618(01)00154-5.
  • Strazielle, C., Lalonde, R., Amdiss, F., Botez, M. I., Hébert, C., & Reader, T. A. (1998). Distribution of dopamine transporters in basal ganglia of cerebellar ataxic mice by [125I]RTI-121 quantitative autoradiography. Neurochemistry International, 32(1), 61–68. doi:10.1016/s0197-0186(97)00042-9.
  • Tseng, K. W., Lu, K. S., & Chien, C. L. (2006). A possible cellular mechanism of neuronal loss in the dorsal root ganglia of dystonia musculorum (dt) mice. Journal of Neuropathology and Experimental Neurology, 65(4), 336–347. doi:10.1097/01.jnen.0000218448.39944.f1.
  • Tseng, K. W., Chau, Y. P., Yang, M. F., Lu, K. S., & Chien, C. L. (2008). Abnormal cellular translocation of α-internexin in spinal motor neurons of dystonia musculorum mice. The Journal of Comparative Neurology, 507(1), 1053–1064. doi:10.1002/cne.21606.
  • Tseng, K. W., Peng, M. L., Wen, Y. C., Liu, K. J., & Chien, C. L. (2011). Neuronal degeneration in autonomic nervous system of dystonia musculorum mice. Journal of Biomedical Science, 18(1), 9. doi:10.1186/1423-0127-18-9.
  • Yang, Y., Bauer, C., Strasser, G., Wollman, R., Julien, J. P., & Fuchs, E. (1999). Integrators of the cytoskeleton that stabilize microtubules. Cell, 98(2), 229–238. doi:10.1016/s0092-8674(00)81017-x.
  • Yang, Y., Dowling, J., Yu, Q. C., & Kouklis, P., Cleveland, D. W., & Fuchs, E. (1996). An essential cytoskeletal linker protein connecting actin microfilaments to intermediate filaments. Cell, 86(4), 655–665. doi:10.1016/s0092-8674(00)80138-5.
  • Yoshioka, N. (2023). Roles of dystonin isoforms in the maintenance of neural, muscle, and cutaneous tissues. Anatomical Science International, 99(1), 7–16. doi:10.1007/s12565-023-00739-1.
  • Yoshioka, N., Kurose, M., Yano, M., Tran, D. M., Okuda, S., Mori-Ochiai, Y., Horie, M., Nagai, T., Nishino, I., Shibata, S., & Takebayashi, H. (2022). Isoform-specific mutation in Dystonin-b gene causes late-onset protein aggregate myopathy and cardiomyopathy. eLife, 11, e78419. doi:10.7554/eLife.78419.
  • Yoshioka, N., Kabata, Y., Kuriyama, M., Bizen, N., Zhou, L., Tran, D. M., Yano, M., Yoshiki, A., Ushiki, T., Sproule, T. J., Abe, R., & Takebayashi, H. (2020). Diverse dystonin gene mutations cause distinct patterns of Dst isoform deficiency and phenotypic heterogeneity in Dystonia musculorum mice. Disease Models & Mechanisms, 13(5), dmm041608. doi:10.1242/dmm.041608.
  • Young, K. G., & Kothary, R. (2008). Dystonin/Bpag1 is a necessary endoplasmic reticulum/nuclear envelope protein in sensory neurons. Experimental Cell Research, 314(15), 2750–2761. doi:10.1016/j.yexcr.2008.06.021.
  • Young, K. G., & Kothary, R. (2007). Dystonin/Bpag1- a link to what? Cell Motility and the Cytoskeleton, 64(12), 897–905. doi:10.1002/cm.20235.
  • Young, K. G., Pinheiro, B., & Kothary, R. (2006). A Bpag1 isoform involved in cytoskeletal organization surrounding the nucleus. Experimental Cell Research, 312(2), 121–134. doi:10.1016/j.yexcr.2005.10.002.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.